EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy

Abdul Q Khan, Adria Hasan, Snober S Mir, Khalid Rashid, Shahab Uddin, Martin Steinhoff

Seminars in Cancer Biology · 2024-05 · 100 · 1-16

DOI: 10.1016/j.semcancer.2024.03.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024-05. Verfasst von Abdul Q Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar. Electronic address: Akhan42@hamad.qa. Hauptthemen laut MEDLINE: Transcription Factors, Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 296 Literaturangaben. Gefördert von: Hamad Medical Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcription factors (TFs) are essential in controlling gene regulatory networks that determine cellular fate during embryogenesis and tumor development. TFs are the major players in promoting cancer stemness by regulating the function of cancer stem cells (CSCs). Understanding how TFs interact with their downstream targets for determining cell fate during embryogenesis and tumor development is a critical area of research. CSCs are increasingly recognized for their significance in tumorigenesis and patient prognosis, as they play a significant role in cancer initiation, progression, metastasis, and treatment resistance. However, traditional therapies have limited effectiveness in eliminating this subset of cells, allowing CSCs to persist and potentially form secondary tumors. Recent studies have revealed that cancer cells and tumors with CSC-like features also exhibit genes related to the epithelial-to-mesenchymal transition (EMT). EMT-associated transcription factors (EMT-TFs) like TWIST and Snail/Slug can upregulate EMT-related genes and reprogram cancer cells into a stem-like phenotype. Importantly, the regulation of EMT-TFs, particularly through post-translational modifications (PTMs), plays a significant role in cancer metastasis and the acquisition of stem cell-like features. PTMs, including phosphorylation, ubiquitination, and SUMOylation, can alter the stability, localization, and activity of EMT-TFs, thereby modulating their ability to drive EMT and stemness properties in cancer cells. Although targeting EMT-TFs holds potential in tackling CSCs, current pharmacological approaches to do so directly are unavailable. Therefore, this review aims to explore the role of EMT- and CSC-TFs, their connection and impact in cellular development and cancer, emphasizing the potential of TF networks as targets for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsNeoplasmsHumansEpithelial-Mesenchymal TransitionCell DifferentiationNeoplastic Stem CellsCell Line, Tumor

Stichwörter der Autor:innen

Cancer stem cellsDrug resistanceEMTTranscription factors

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar. Electronic address: Akhan42@hamad.qa.
  • Molecular Cell Biology Laboratory, Integral Information and Research Centre-4 (IIRC-4), Integral University, Kursi Road, Lucknow 226026, India; Department of Bioengineering, Faculty of Engineering, Integral University,…
  • Molecular Cell Biology Laboratory, Integral Information and Research Centre-4 (IIRC-4), Integral University, Kursi Road, Lucknow 226026, India; Department of Biosciences, Faculty of Science, Integral University, Kursi R…
  • Department of Urology,Feinberg School of Medicine, Northwestern University, 303 E Superior Street, Chicago, IL 60611, USA.
  • Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Department of Biosciences, Faculty of Science, Integral University, Kursi Road, Lucknow 226026, India; Laboratory Animal…
  • Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar; Department of Dermatology and…

Förderung

  • Hamad Medical Corporation

Zitieren

APA

Khan, A. Q., Hasan, A., Mir, S. S., Rashid, K., Uddin, S., & Steinhoff, M. (2024). Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. Seminars in Cancer Biology, 100, 1-16. https://doi.org/10.1016/j.semcancer.2024.03.002

Vancouver

Khan AQ, Hasan A, Mir SS, Rashid K, Uddin S, Steinhoff M. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. Seminars in Cancer Biology. 2024;100:1-16. doi:10.1016/j.semcancer.2024.03.002

BibTeX
@article{Khan2024,
  author = {Khan, Abdul Q and Hasan, Adria and Mir, Snober S and Rashid, Khalid and Uddin, Shahab and Steinhoff, Martin},
  title = {Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy},
  journal = {Seminars in Cancer Biology},
  year = {2024},
  volume = {100},
  pages = {1--16},
  doi = {10.1016/j.semcancer.2024.03.002}
}
Kostenlos starten →